Associations of MYC protein expression and gene status with breast cancer subtypes and outcome in patients treated with anthracycline-based adjuvant chemotherapy

被引：0
|
作者：
Batistatou, A.
Razis, E.
Bobos, M.
Tsolaki, E.
Timotheadou, E.
Alexopoulou, Z.
Goussia, A.
Gogas, H.
Koutras, A.
Karina, M.
Pentheroudakis, G.
Efstratiou, I.
Petraki, K.
Sotiropoulou, M.
Pavlakis, K.
Koletsa, T.
Kotoula, V.
Fountzilas, G.
机构：
[1] Hellen Cooperat Oncol Grp HeCOG, Athens, Greece
[2] Hlth Data Specialists Ltd, Athens, Greece
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.SABCS15-P5-08-50
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-08-50
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Correlation of MYC Gene and Protein Status With Breast Cancer Subtypes and Outcome of Patients Treated With Anthracycline-Based Adjuvant Chemotherapy. Pooled Analysis of 2 Hellenic Cooperative Group Phase III Trials
    Batistatou, Anna
    Kotoula, Vassiliki
    Bobos, Mattheos
    Kouvatseas, George
    Zagouri, Flora
    Tsolaki, Eleftheria
    Gogas, Helen
    Koutras, Angelos
    Pentheroudakis, George
    Timotheadou, Eleni
    Pervana, Stavroula
    Goussia, Anna
    Petraki, Kalliopi
    Sotiropoulou, Maria
    Koletsa, Triantafyllia
    Razis, Evangelia
    Kosmidis, Paris
    Aravantinos, Gerasimos
    Papadimitriou, Christos
    Pectasides, Dimitrios
    Fountzilas, George
    CLINICAL BREAST CANCER, 2018, 18 (01) : 53 - +
  • [2] Gene expression profile predicts outcome after anthracycline-based adjuvant chemotherapy in early breast cancer
    Bertucci, Francois
    Borie, Nathalie
    Roche, Henri
    Bachelot, Thomas
    Le Doussal, Jean-Marc
    Macgrogan, Gaetan
    Debono, Stephane
    Martinec, Agnes
    Treilleux, Isabelle
    Finetti, Pascal
    Esterni, Benjamin
    Extra, Jean-Marc
    Geneve, Jean
    Hermitte, Fabienne
    Chabannon, Christian
    Jacquemier, Jocelyne
    Martin, Anne-Laure
    Longy, Michel
    Maraninchi, Dominique
    Fert, Vincent
    Birnbaum, Daniel
    Viens, Patrice
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 127 (02) : 363 - 373
  • [3] Gene expression profile predicts outcome after anthracycline-based adjuvant chemotherapy in early breast cancer
    François Bertucci
    Nathalie Borie
    Henri Roche
    Thomas Bachelot
    Jean-Marc Le Doussal
    Gaëtan Macgrogan
    Stéphane Debono
    Agnès Martinec
    Isabelle Treilleux
    Pascal Finetti
    Benjamin Esterni
    Jean-Marc Extra
    Jean Geneve
    Fabienne Hermitte
    Christian Chabannon
    Jocelyne Jacquemier
    Anne-Laure Martin
    Michel Longy
    Dominique Maraninchi
    Vincent Fert
    Daniel Birnbaum
    Patrice Viens
    Breast Cancer Research and Treatment, 2011, 127 : 363 - 373
  • [4] Anthracycline-based adjuvant chemotherapy in breast cancer
    Gray, Richard
    LANCET, 2010, 375 (9729): : 1870 - 1871
  • [5] Optimal delivery of anthracycline-based chemotherapy in the adjuvant setting improves outcome of breast cancer patients
    Chirivella, Isabel
    Bermejo, Begona
    Insa, Amelia
    Perez-Fidalgo, Alejandro
    Magro, Ana
    Rosello, Susana
    Garcia-Garre, Elisa
    Martin, Paloma
    Bosch, Ana
    Lluch, Ana
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 114 (03) : 479 - 484
  • [6] Optimal delivery of anthracycline-based chemotherapy in the adjuvant setting improves outcome of breast cancer patients
    Isabel Chirivella
    Begoña Bermejo
    Amelia Insa
    Alejandro Pérez-Fidalgo
    Ana Magro
    Susana Rosello
    Elisa García-Garre
    Paloma Martín
    Ana Bosch
    Ana Lluch
    Breast Cancer Research and Treatment, 2009, 114 : 479 - 484
  • [7] Changes in protein expression in breast cancer after anthracycline-based chemotherapy
    Lee, Ho-chang
    Lee, JaeOk
    Park, In Ae
    KOREAN JOURNAL OF PATHOLOGY, 2007, 41 (03) : 165 - 170
  • [8] Benefits of dexrazoxane in female patients with stage II breast cancer treated with anthracycline-based adjuvant chemotherapy
    Schnirer, I. I.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [9] BCL11A gene status and prediction of survival in triple negative breast cancer (TNBC) treated with anthracycline-based adjuvant chemotherapy
    Bouchalova, K.
    Svoboda, M.
    Kharaishvili, G.
    Vrbkova, J.
    Slavkovsky, R.
    Bouchal, J.
    Navratil, J.
    Koudelakova, V.
    Trojanec, R.
    Cwiertka, K.
    Hajduch, M.
    Kolar, Z.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S48 - S48
  • [10] Predictive role molecular subtypes of cyclooxygenase-2 in basal-like breast cancer patients treated with adjuvant anthracycline-based chemotherapy
    Melucci, Elisa
    CELLULAR ONCOLOGY, 2008, 30 (02) : 157 - 158
12345